Neuregulin signaling and heart failure

Current Heart Failure Reports

Volumn 7, Issue 1, 2010, Pages 42-47

  Jiang, Zhenggang ^a   Zhou, Mingdong ^a  

^a Zensun (Shanghai) Sci and Tech Ltd   (China)

Author keywords

Heart failure; NRG 1; Signaling

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CARDIAC MYOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; MYOSIN LIGHT CHAIN KINASE; NEU DIFFERENTIATION FACTOR; PLACEBO; TRASTUZUMAB;

ANGIOGENESIS; ANTIATHEROSCLEROSIS EFFECT; CALCIUM HOMEOSTASIS; CARDIOMYOPATHY; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG ACTIVITY; DRUG EFFECT; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE CELL; HOSPITAL READMISSION; HUMAN; INOTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SARCOMERE; SHORT COURSE THERAPY; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; NEUREGULIN-1; SIGNAL TRANSDUCTION;

EID: 77949272136     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-010-0003-y     Document Type: Review

References (53)

1. S Britsch 2007 The neuregulin-I/ErbB signaling system in development and disease Adv Anat Embryol Cell Biol 190 1 65 10.1007/978-3-540-37107-6-1 17432114
2. D Meyer T Yamaai A Garratt, et al. 1997 Isoform-specific expression and function of neuregulin Development 124 3575 3586 1:CAS:528:DyaK2sXmvVWgsb4%3D 9342050
3. DL Falls 2003 Neuregulins: functions, forms, and signaling strategies Exp Cell Res 284 14 30 10.1016/S0014-4827(02)00102-7 1:CAS:528:DC%2BD3sXitVyltr8%3D 12648463 (Pubitemid 36335807)
4. EM Bublil Y Yarden 2007 The EGF receptor family: spearheading a merger of signaling and therapeutics Curr Opin Cell Biol 19 124 134 10.1016/j.ceb.2007. 02.008 1:CAS:528:DC%2BD2sXjt1Slu7w%3D 17314037 (Pubitemid 46386405)
5. • Pentassuglia L, Sawyer DB: The role of Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res 2009, 315:627-637. This article reviews recent advances in understanding the role of NRG-1 in the cardiac development and maintenance of heart function.
6. D Meyer C Birchmeier 1995 Multiple essential functions of neuregulin in development Nature 378 386 390 10.1038/378386a0 1:CAS:528:DyaK2MXps1ams7o%3D 7477375
7. M Gassmann F Casagranda D Orioli, et al. 1995 Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor Nature 378 390 394 10.1038/378390a0 1:CAS:528:DyaK2MXps1ams7s%3D 7477376
8. KF Lee H Simon H Chen, et al. 1995 Requirement for neuregulin receptor erbB2 in neural and cardiac development Nature 378 394 398 10.1038/378394a0 1:CAS:528:DyaK2MXps1ams7g%3D 7477377
9. SA Crone YY Zhao L Fan, et al. 2002 ErbB2 is essential in the prevention of dilated cardiomyopathy Nat Med 8 459 465 10.1038/nm0502-459 1:CAS:528:DC%2BD38Xjt1Kgtbs%3D 11984589 (Pubitemid 34546747)
10. H García-Rivello J Taranda M Said, et al. 2005 Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle Am J Physiol Heart Circ Physiol 289 H1153 H1160 10.1152/ajpheart.00048.2005 15863464 (Pubitemid 41208959)
11. YY Zhao DR Sawyer RR Baliga, et al. 1998 Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes J Biol Chem 273 10261 10269 10.1074/jbc.273.17.10261 1:CAS:528:DyaK1cXivFKntro%3D 9553078 (Pubitemid 28227629)
12. X Liu X Gu Z Li, et al. 2006 Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy J Am Coll Cardiol 48 1438 1447 10.1016/j.jacc.2006.05.057 1:CAS:528:DC%2BD28XhtVagtb7I 17010808 (Pubitemid 44436803)
13. •• Bersell K, Arab S, Haring B, Kühn B: Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 2009, 138: 257-270. This study first reported on NRG-1-induced proliferation of differentiated cardiomyocytes and further emphasized the therapeutic effects of NRG-1 on ischemic heart failure.
14. S Rohrbach B Niemann RE Silber J Holtz 2005 Neuregulin receptors erbB2 and erbB4 in failing human myocardium-depressed expression and attenuated activation Basic Res Cardiol 100 240 249 10.1007/s00395-005-0514-4 1:CAS:528:DC%2BD2MXkslKls7s%3D 15685397 (Pubitemid 41348815)
15. K Lemmens K Doggen GW De Keulenaer 2007 Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure Circulation 116 954 960 10.1161/CIRCULATIONAHA.107.690487 1:CAS:528:DC%2BD2sXovFyhsrk%3D 17709650 (Pubitemid 47300920)
16. •• Gao R, Zhang J, Cheng L, et al.: A phase II, randomized, double-blind, multi-center, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 (rhNRG-1) in patients with chronic heart failure (CHF). J Am Coll Cardiol (In press). This article provides the first report demonstrating the therapeutic role of NRG-1 for the treatment of chronic heart failure in humans. Recombinant NRG-1 improved the cardiac function of patients with congestive heart failure by increasing left ventricular ejection fraction percentage, and showed a capability of anti-remodeling by decreasing end-systolic volume and end-diastolic volume compared with pretreatment.
17. RR Baliga DR Pimental YY Zhao, et al. 1999 NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK Am J Physiol 277 H2026 H2037 1:CAS:528:DyaK1MXns1yrtrc%3D 10564160
18. X Peng MS Kraus H Wei, et al. 2006 Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice J Clin Invest 116 217 227 10.1172/JCI24497 1:CAS:528:DC%2BD28XjslOgsA%3D%3D 16374517 (Pubitemid 43121807)
19. X Peng X Wu JE Druso, et al. 2008 Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice Proc Natl Acad Sci U S A 105 6638 6643 10.1073/pnas.0802319105 1:CAS:528:DC%2BD1cXmtVOmt7w%3D 18448675 (Pubitemid 351754559)
20. B Kovacic-Milivojević F Roediger EA Almeida, et al. 2001 Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy Mol Biol Cell 12 2290 2307 11514617
21. H Mansour PP de Tombe AM Samarel B Russell 2004 Restoration of resting sarcomere length after uniaxial static strain is regulated by protein kinase Cepsilon and focal adhesion kinase Circ Res 94 642 649 10.1161/01.RES. 0000121101.32286.C8 1:CAS:528:DC%2BD2cXitVGksrY%3D 14963000 (Pubitemid 38387747)
22. Y Kuramochi X Guo DB Sawyer 2006 Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes J Mol Cell Cardiol 41 228 235 10.1016/j.yjmcc.2006.04.007 1:CAS:528:DC%2BD28XntlGhs74%3D 16769082 (Pubitemid 44080212)
23. CD Willey S Balasubramanian 2003 Rodríguez Rosas MC, et al.: Focal complex formation in adult cardiomyocytes is accompanied by the activation of beta3 integrin and c-Src J Mol Cell Cardiol 35 671 683 10.1016/S0022-2828(03) 00112-3 1:CAS:528:DC%2BD3sXkt1Gkurc%3D 12788385 (Pubitemid 36677451)
24. SB Scruggs AC Hinken A Thawornkaiwong, et al. 2009 Ablation of ventricular myosin regulatory light chain phosphorylation in mice causes cardiac dysfunction in situ and affects neighboring myofilament protein phosphorylation J Biol Chem 284 5097 5106 10.1074/jbc.M807414200 1:CAS:528:DC%2BD1MXhvVSntr4%3D 19106098
25. D Dumka J Talent I Akopova, et al. 2006 E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics Am J Physiol Heart Circ Physiol 291 H2098 H2106 10.1152/ajpheart.00396.2006 1:CAS:528:DC%2BD28Xht1GnsLnI 16751284 (Pubitemid 44776634)
26. H Aoki J Sadoshima S Izumo 2000 Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro Nat Med 6 183 188 10.1038/72287 1:CAS:528:DC%2BD3cXosF2jsg%3D%3D 10655107 (Pubitemid 30082363)
27. • Seguchi O, Takashima S, Yamazaki S, et al.: A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest 2007, 117:2812-2824. This study provided the first report on the identification of cMLCK from human myocardia and further demonstrated that knockdown of cMLCK expression in cardiomyocytes results in immature sarcomere structures.
28. • Chan JY, Takeda M, Briggs LE, et al.: Identification of cardiac-specific myosin light chain kinase. Circ Res 2008, 102:571-580. This study reports that Nkx2-5 regulated cMLCK expression and further demonstrates that cMLCK modulate MLC2 phosphorylation, sarcomere organization, and cardiomyocytes contraction.
29. Z Wang G Xu Y Wu, et al. 2008 Neuregulin-1 promotes cardiomyocyte differentiation of genetically engineered embryonic stem cell clones BMB Rep 41 699 704 1:CAS:528:DC%2BD1cXhtlyqsr7E 18959815
30. Z Wang G Xu Y Wu, et al. 2009 Neuregulin-1 enhances differentiation of cardiomyocytes from embryonic stem cells Med Biol Eng Comput 47 41 48 10.1007/s11517-008-0383-2 18712425
31. KB Pasumarthi LJ Field 2002 Cardiomyocyte cell cycle regulation Circ Res 90 1044 1054 10.1161/01.RES.0000020201.44772.67 1:CAS:528:DC%2BD38XktlSnsLY%3D 12039793 (Pubitemid 34627902)
32. JW Schneider AY Chang TP Rocco 2001 Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart Semin Oncol 28 18 26 10.1016/S0093-7754(01)90278-7 1:CAS:528:DC%2BD3MXpt1Wgu7w%3D 11706392
33. Y Kuramochi CC Lim X Guo, et al. 2004 Myocyte contractile activity modulates norepinephrine cytotoxicity and survival effects of neuregulin-1beta Am J Physiol Cell Physiol 286 C222 C229 10.1152/ajpcell.00312.2003 1:CAS:528:DC%2BD2cXhsFarsr8%3D 14522821
34. K Okoshi M Nakayama X Yan, et al. 2004 Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion Circulation 110 713 717 10.1161/01.CIR.0000138109.32748.80 1:CAS:528:DC%2BD2cXmtFOgsr4%3D 15289373 (Pubitemid 39056271)
35. R Fukazawa TA Miller Y Kuramochi, et al. 2003 Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt J Mol Cell Cardiol 35 1473 1479 10.1016/j.yjmcc.2003.09.012 1:CAS:528:DC%2BD3sXpsVSntr0%3D 14654373 (Pubitemid 37491190)
36. W Miao Z Luo RN Kitsis K Walsh 2000 Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo J Mol Cell Cardiol 32 2397 2402 10.1006/jmcc.2000.1283 1:CAS:528:DC%2BD3cXos1KhsrY%3D 11113015 (Pubitemid 32039789)
37. Y Fujio T Nguyen D Wencker, et al. 2000 Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart Circulation 101 660 667 1:CAS:528:DC%2BD3cXhtlGntLs%3D 10673259
38. S Das GA Cordis N Maulik DK Das 2005 Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation Am J Physiol Heart Circ Physiol 288 H328 H235 10.1152/ajpheart.00453. 2004 1:CAS:528:DC%2BD2MXhtVCqt7w%3D 15345477 (Pubitemid 40023863)
39. A Dhanasekaran SK Gruenloh JN Buonaccorsi, et al. 2008 Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia Am J Physiol Heart Circ Physiol 294 H724 H735 10.1152/ajpheart.00979.2007 1:CAS:528:DC%2BD1cXit1yls7c%3D 18055514 (Pubitemid 351253284)
40. Z Kubalova D Terentyev S Viatchenko-Karpinski, et al. 2005 Abnormal intrastore calcium signaling in chronic heart failure Proc Natl Acad Sci U S A 102 14104 14109 10.1073/pnas.0504298102 1:CAS:528:DC%2BD2MXhtVOqsbfP 16172392 (Pubitemid 41377710)
41. LO Go MC Moschella J Watras, et al. 1995 Differential regulation of two types of intracellular calcium release channels during end-stage heart failure J Clin Invest 95 888 894 10.1172/JCI117739 1:CAS:528:DyaK2MXjsV2rsbo%3D 7860772
42. A Pathak F del Monte W Zhao, et al. 2005 Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1 Circ Res 96 756 766 10.1161/01.RES.0000161256.85833.fa 1:CAS:528:DC%2BD2MXjtVWntLo%3D 15746443 (Pubitemid 40559515)
43. MT Jiang AJ Lokuta EF Farrell, et al. 2002 Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure Circ Res 91 1015 1022 10.1161/01.RES.0000043663.08689.05 1:CAS:528:DC%2BD38XoslOqt70%3D 12456487 (Pubitemid 35416638)
44. LK MacDougall LR Jones P Cohen 1991 Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban Eur J Biochem 196 725 734 10.1111/j.1432-1033.1991.tb15871.x 1:CAS:528: DyaK3MXitVChsLs%3D 1849481
45. H Verboomen F Wuytack H De Smedt, et al. 1992 Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban Biochem J 286 591 595 1:CAS:528:DyaK38Xls1Kjtro%3D 1326945
46. RC Gupta S Mishra S Rastogi, et al. 2003 Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts Am J Physiol Heart Circ Physiol 285 H2373 H2381 1:CAS:528:DC%2BD2cXhsVSi 14613911
47. A El-Armouche T Rau O Zolk, et al. 2003 Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes FASEB J 17 437 439 1:CAS:528:DC%2BD3sXitFaqsbc%3D 12514122
48. K Lemmens P Fransen SU Sys, et al. 2004 Neuregulin-1 induces a negative inotropic effect in cardiac muscle: role of nitric oxide synthase Circulation 109 324 326 10.1161/01.CIR.0000114521.88547.5E 1:CAS:528:DC%2BD2cXks1Citw%3D%3D 14732742 (Pubitemid 38133898)
49. DN Amin K Hida DR Bielenberg M Klagsbrun 2006 Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors Cancer Res 66 2173 2180 10.1158/0008-5472.CAN-05-3387 1:CAS:528:DC%2BD28XhsFalsrk%3D 16489018 (Pubitemid 43294927)
50. E Iivanainen I Paatero SM Heikkinen, et al. 2007 Intra- and extracellular signaling by endothelial neuregulin-1 Exp Cell Res 313 2896 2909 10.1016/j.yexcr.2007.03.042 1:CAS:528:DC%2BD2sXosFyqtrg%3D 17499242 (Pubitemid 47126431)
51. D Panutsopulos DL Arvanitis C Tsatsanis, et al. 2005 Expression of heregulin in human coronary atherosclerotic lesions J Vasc Res 42 463 474 10.1159/000088100 1:CAS:528:DC%2BD2MXhtFWmurnI 16155362 (Pubitemid 41527601)
52. F Sigala S Georgopoulos E Papalambros, et al. 2006 Heregulin, cysteine rich-61 and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with clinical data Eur J Vasc Endovasc Surg 32 238 245 10.1016/j.ejvs.2006.01.026 1:STN:280:DC%2BD28vpt1Glsg%3D%3D 16774841 (Pubitemid 44204108)
53. G Xu T Watanabe Y Iso, et al. 2009 Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis Circ Res 105 500 510 10.1161/CIRCRESAHA.109.193870 1:CAS:528:DC%2BD1MXhtVekt7%2FJ 19644050